Aimmune Therapeutics
Founder Bryan Walser
Country: USA | Funding: $540M (+)
Aimmune Therapeutics is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies. Permanently closed
Aimmune Therapeutics is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies. Permanently closed
